8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Feb 25, 2026·SEC
Material company update
Dec 18, 2025·SEC
Aspen Aerogels, Inc.(ASPN)Earnings, Financials & Key Ratios
ASPN•NYSE
$4.12
$341M mkt cap·Price updated May 6, 2026
AboutAspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.Show more
- Revenue$271M-40.1%
- EBITDA-$6M-107.9%
- Net Income-$390M-3012.5%
- EPS (Diluted)-4.74-2888.2%
- Gross Margin16.97%-58.0%
- EBITDA Margin-2.3%-113.2%
- Operating Margin-18.96%-257.4%
- Net Margin-143.69%-4963.5%
- ROE-91.64%-3877.7%
- ROIC-9.48%-224.9%
- Debt/Equity0.61+90.0%
- Interest Coverage0.94-58.6%
ASPN Key Insights
Aspen Aerogels, Inc. (ASPN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 22.0%
- ✓Trading at only 1.4x book value
✗Weaknesses
- ✗Profits declining 78.0% over 5 years
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ASPN Price & Volume
Aspen Aerogels, Inc. (ASPN) stock price & volume — 10-year historical chart
Loading chart...
ASPN Growth Metrics
Aspen Aerogels, Inc. (ASPN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.27%
5 Years22.01%
3 Years14.55%
TTM-40.11%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-3012.54%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-3142.36%
Return on Capital
10 Years-17.87%
5 Years-13.45%
3 Years-3.21%
Last Year-9.1%
ASPN Recent Earnings
Aspen Aerogels, Inc. (ASPN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)
Q1 2026Latest
Feb 25, 2026EPS
$0.34
Est $0.27
-25.9%
Revenue
$41M
Est $44M
-6.6%
Q4 2025
Nov 6, 2025EPS
$0.06
Est $0.21
+72.1%
Revenue
$73M
Est $44M
+64.4%
Q3 2025
Aug 7, 2025EPS
$0.04
Est $0.12
+66.7%
Revenue
$78M
Est $70M
+10.7%
Q2 2025
May 8, 2025EPS
$0.06
Est $0.07
+14.3%
Revenue
$79M
Est $89M
-12.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $0.34vs $0.27-25.9% | $41Mvs $44M-6.6% |
| Q4 2025 | Nov 6, 2025 | $0.06vs $0.21+72.1% | $73Mvs $44M+64.4% |
| Q3 2025 | Aug 7, 2025 | $0.04vs $0.12+66.7% | $78Mvs $70M+10.7% |
| Q2 2025 | May 8, 2025 | $0.06vs $0.07+14.3% | $79Mvs $89M-12.0% |
Based on last 12 quarters of dataView full earnings history →
ASPN Peer Comparison
Aspen Aerogels, Inc. (ASPN) competitors in Building envelope and openings — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 KALU | 2.92B | 180.42 | 26.65 | 11.54% | 4.14% | 18.68% | 1.36 | |
 UFPI | 4.79B | 84.26 | 16.85 | -4.99% | 4.27% | 8.41% | 0.07 | |
 MTRN | 4.09B | 196.46 | 54.88 | 6.05% | 3.99% | 8.17% | 0.64 | |
 OC | 9.89B | 123.02 | -19.65 | -7.95% | -5.42% | -12.38% | 1.58 | |
 AWI | 7.09B | 166.23 | 23.48 | 12.11% | 18.59% | 34.81% | 0.59 | |
 IBP | 8.06B | 299.13 | 30.81 | 1% | 8.93% | 39.12% | 1.48 | |
 ROCK | 1.12B | 37.90 | 11.66 | -13.24% | 8.59% | 9.87% | 0.11 | |
 JELD | 149.31M | 1.73 | -0.24 | -14.95% | -16.09% | -291.23% | 15.81 |
Compare ASPN vs Peers
Aspen Aerogels, Inc. (ASPN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ASPN Income Statement
Aspen Aerogels, Inc. (ASPN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 111.63M | 104.36M | 139.38M | 100.27M | 121.62M | 180.36M | 238.72M | 452.7M | 271.1M |
| Revenue Growth % | -5.19% | -6.51% | 33.55% | -28.06% | 21.29% | 48.3% | 32.35% | 89.64% | -40.11% |
| Cost of Goods Sold | 92.96M | 91.69M | 113.09M | 85.68M | 111.69M | 175.39M | 181.8M | 269.8M | 225.1M |
| COGS % of Revenue | 83.27% | 87.86% | 81.14% | 85.45% | 91.83% | 97.24% | 76.16% | 59.6% | 83.03% |
| Gross Profit | 18.67M▲ 0% | 12.67M▼ 32.1% | 26.28M▲ 107.5% | 14.59M▼ 44.5% | 9.94M▼ 31.9% | 4.98M▼ 49.9% | 56.92M▲ 1043.9% | 182.9M▲ 221.3% | 46M▼ 74.9% |
| Gross Margin % | 16.73% | 12.14% | 18.86% | 14.55% | 8.17% | 2.76% | 23.84% | 40.4% | 16.97% |
| Gross Profit Growth % | -19.9% | -32.15% | 107.47% | -44.48% | -31.91% | -49.92% | 1043.91% | 221.32% | -74.85% |
| Operating Expenses | 37.81M | 39.23M | 40.44M | 36.16M | 50.54M | 84.22M | 106.12M | 128.36M | 97.39M |
| OpEx % of Revenue | 33.87% | 37.59% | 29.02% | 36.06% | 41.55% | 46.7% | 44.46% | 28.35% | 35.92% |
| Selling, General & Admin | 31.63M | 32.91M | 32.04M | 27.43M | 39.09M | 67.29M | 89.77M | 106.8M | 40.91B |
| SG&A % of Revenue | 28.33% | 31.53% | 22.99% | 27.36% | 32.14% | 37.31% | 37.6% | 23.59% | 15090.98% |
| Research & Development | 6.18M | 6.32M | 8.41M | 8.73M | 11.44M | 16.93M | 16.36M | 18.05M | 6.3B |
| R&D % of Revenue | 5.54% | 6.05% | 6.03% | 8.71% | 9.41% | 9.39% | 6.85% | 3.99% | 2322.04% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.51M | -47.11B |
| Operating Income | -19.14M▲ 0% | -33.92M▼ 77.2% | -14.16M▲ 58.3% | -21.57M▼ 52.3% | -40.6M▼ 88.2% | -79.25M▼ 95.2% | -49.2M▲ 37.9% | 54.53M▲ 210.8% | -51.39M▼ 194.2% |
| Operating Margin % | -17.14% | -32.5% | -10.16% | -21.51% | -33.38% | -43.94% | -20.61% | 12.05% | -18.96% |
| Operating Income Growth % | -70.55% | -77.24% | 58.25% | -52.33% | -88.23% | -95.19% | 37.91% | 210.84% | -194.24% |
| EBITDA | -8.38M | -23.13M | -3.95M | -11.37M | -31.16M | -70.02M | -31.03M | 78.95M | -6.24M |
| EBITDA Margin % | -7.51% | -22.16% | -2.83% | -11.34% | -25.62% | -38.82% | -13% | 17.44% | -2.3% |
| EBITDA Growth % | -513.24% | -175.9% | 82.94% | -188.17% | -174.02% | -124.73% | 55.69% | 354.45% | -107.9% |
| D&A (Non-Cash Add-back) | 10.75M | 10.79M | 10.21M | 10.2M | 9.44M | 9.22M | 18.18M | 24.41M | 45.16M |
| EBIT | -19.14M | -33.92M | -14.16M | -21.57M | -36.87M | -77.63M | -40.48M | 27.05M | 5.67B |
| Net Interest Income | -185K | -524K | -406K | -240K | -229K | -3.49M | 1.21M | -11.96M | -6.06B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 1.62M | 6.53M | 0 | 0 |
| Interest Expense | 185K | 524K | 406K | 240K | 229K | 5.11M | 5.33M | 11.96M | 6.06B |
| Other Income/Expense | -185K | -524K | -406K | -240K | 3.5M | -3.49M | 3.39M | -39.45M | -335.77M |
| Pretax Income | -19.32M▲ 0% | -34.44M▼ 78.3% | -14.56M▲ 57.7% | -21.81M▼ 49.7% | -37.09M▼ 70.1% | -82.74M▼ 123.0% | -45.81M▲ 44.6% | 15.09M▲ 132.9% | -387.16M▼ 2665.8% |
| Pretax Margin % | -17.31% | -33% | -10.45% | -21.75% | -30.5% | -45.87% | -19.19% | 3.33% | -142.81% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71M | 2.39M |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11.36% | -0.62% |
| Net Income | -19.32M▲ 0% | -34.44M▼ 78.3% | -14.56M▲ 57.7% | -21.81M▼ 49.7% | -37.09M▼ 70.1% | -82.74M▼ 123.0% | -45.81M▲ 44.6% | 13.38M▲ 129.2% | -389.55M▼ 3012.5% |
| Net Margin % | -17.31% | -33% | -10.45% | -21.75% | -30.5% | -45.87% | -19.19% | 2.95% | -143.69% |
| Net Income Growth % | -60.7% | -78.25% | 57.71% | -49.74% | -70.09% | -123.05% | 44.63% | 129.2% | -3012.54% |
| Net Income (Continuing) | -19.32M | -34.44M | -14.56M | -21.81M | -37.09M | -82.74M | -45.81M | 13.38M | -389.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.83▲ 0% | -1.45▼ 74.7% | -0.20▲ 86.2% | -0.45▼ 125.0% | -0.92▼ 104.4% | -2.19▼ 138.0% | -0.66▲ 69.9% | 0.17▲ 125.8% | -4.74▼ 2888.2% |
| EPS Growth % | -59.62% | -74.7% | 86.21% | -125% | -104.44% | -138.04% | 69.86% | 125.76% | -2888.24% |
| EPS (Basic) | -0.83 | -1.45 | -0.20 | -0.45 | -0.92 | -2.19 | -0.66 | 0.17 | -4.74 |
| Diluted Shares Outstanding | 23.39M | 23.74M | 24.1M | 26.38M | 30.43M | 39.36M | 69.44M | 80.31M | 82.66M |
| Basic Shares Outstanding | 23.39M | 23.74M | 24.1M | 26.38M | 30.43M | 39.36M | 69.44M | 77.53M | 82.66M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ASPN Balance Sheet
Aspen Aerogels, Inc. (ASPN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 47.66M | 37.25M | 45.77M | 47.12M | 112.15M | 369.69M | 266.33M | 409.45M | 242.05M |
| Cash & Short-Term Investments | 10.69M | 3.33M | 3.63M | 16.5M | 76.56M | 281.33M | 139.72M | 220.88M | 156.86M |
| Cash Only | 10.69M | 3.33M | 3.63M | 16.5M | 76.56M | 281.33M | 139.72M | 220.88M | 156.86M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 26.76M | 25.57M | 32.25M | 15.7M | 20.43M | 57.35M | 70M | 109.1M | 35.27M |
| Days Sales Outstanding | 87.51 | 89.41 | 84.47 | 57.14 | 61.3 | 116.06 | 107.02 | 87.97 | 47.49 |
| Inventory | 8.91M | 7.32M | 8.77M | 13.1M | 11.99M | 22.54M | 39.19M | 47.55M | 38.25M |
| Days Inventory Outstanding | 35 | 29.13 | 28.3 | 55.8 | 39.17 | 46.9 | 78.68 | 64.33 | 62.02 |
| Other Current Assets | 1.29M | 1.04M | 1.11M | 0 | 0 | 8.46M | 17.42M | 31.91M | 11.68M |
| Total Non-Current Assets | 76.15M | 61.77M | 57.73M | 50.3M | 70.8M | 273.73M | 436.72M | 485.7M | 164.63M |
| Property, Plant & Equipment | 76.07M | 61.7M | 57.65M | 50.22M | 69.31M | 271.21M | 434.44M | 480.13M | 122.55M |
| Fixed Asset Turnover | 1.47x | 1.69x | 2.42x | 2.00x | 1.75x | 0.67x | 0.55x | 0.94x | 2.21x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 86K | 73K | 84K | 84K | 1.5M | 2.52M | 2.28M | 5.57M | 42.08M |
| Total Assets | 123.81M▲ 0% | 99.02M▼ 20.0% | 103.5M▲ 4.5% | 97.42M▼ 5.9% | 182.95M▲ 87.8% | 643.42M▲ 251.7% | 703.05M▲ 9.3% | 895.14M▲ 27.3% | 406.68M▼ 54.6% |
| Asset Turnover | 0.90x | 1.05x | 1.35x | 1.03x | 0.66x | 0.28x | 0.34x | 0.51x | 0.67x |
| Asset Growth % | -8.06% | -20.02% | 4.52% | -5.87% | 87.79% | 251.68% | 9.27% | 27.32% | -54.57% |
| Total Current Liabilities | 21.57M | 23.07M | 30.43M | 13.93M | 36.55M | 78.94M | 78.09M | 110.11M | 62.02M |
| Accounts Payable | 10.65M | 12.39M | 12.6M | 5.35M | 17.44M | 54.73M | 51.09M | 44.36M | 13.24M |
| Days Payables Outstanding | 41.83 | 49.33 | 40.65 | 22.8 | 57 | 113.89 | 102.58 | 60.01 | 21.47 |
| Short-Term Debt | 3.75M | 4.18M | 3.12M | 1.61M | 0 | 0 | 0 | 23.78M | 34.57M |
| Deferred Revenue (Current) | 1.3M | 2.63M | 5.62M | 2.04M | 6.05M | 5.85M | 2.32M | 2.2M | 1.26M |
| Other Current Liabilities | 1.23M | 1.11M | 1.58M | 2.59M | 8.99M | 12.47M | 16.88M | 19.37M | 12.95M |
| Current Ratio | 2.21x | 1.61x | 1.50x | 3.38x | 3.07x | 4.68x | 3.41x | 3.72x | 3.90x |
| Quick Ratio | 1.80x | 1.30x | 1.22x | 2.44x | 2.74x | 4.40x | 2.91x | 3.29x | 3.29x |
| Cash Conversion Cycle | 80.69 | 69.21 | 72.11 | 90.15 | 43.48 | 49.07 | 83.12 | 92.28 | 88.03 |
| Total Non-Current Liabilities | 1.3M | 5.7M | 14.08M | 15.64M | 17.99M | 117.04M | 136.9M | 170.33M | 109.14M |
| Long-Term Debt | 0 | 0 | 0 | 2.06M | 0 | 103.58M | 114.99M | 137.09M | 79.8M |
| Capital Lease Obligations | 0 | 0 | 4.29M | 3.6M | 12.99M | 13.46M | 21.91M | 33.23M | 29.34M |
| Deferred Tax Liabilities | 0 | 0 | -9.79M | 434K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.3M | 5.7M | 9.79M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 22.87M | 28.77M | 44.51M | 29.57M | 54.55M | 195.98M | 214.99M | 280.44M | 171.16M |
| Total Debt | 3.75M | 4.18M | 8.45M | 8.31M | 15.24M | 119.4M | 138.77M | 197.38M | 143.71M |
| Net Debt | -6.94M | 854K | 4.82M | -8.19M | -61.33M | -161.93M | -951K | -23.5M | -13.15M |
| Debt / Equity | 0.04x | 0.06x | 0.14x | 0.12x | 0.12x | 0.27x | 0.28x | 0.32x | 0.61x |
| Debt / EBITDA | - | - | - | - | - | - | - | 2.50x | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -0.30x | - |
| Interest Coverage | -103.44x | -64.73x | -34.87x | -89.87x | -160.98x | -15.19x | -7.60x | 2.26x | 0.94x |
| Total Equity | 100.94M▲ 0% | 70.25M▼ 30.4% | 58.99M▼ 16.0% | 67.85M▲ 15.0% | 128.41M▲ 89.2% | 447.44M▲ 248.4% | 488.06M▲ 9.1% | 614.71M▲ 25.9% | 235.52M▼ 61.7% |
| Equity Growth % | -12.65% | -30.4% | -16.03% | 15.02% | 89.25% | 248.45% | 9.08% | 25.95% | -61.69% |
| Book Value per Share | 4.32 | 2.96 | 2.45 | 2.57 | 4.22 | 11.37 | 7.03 | 7.65 | 2.85 |
| Total Shareholders' Equity | 100.94M | 70.25M | 58.99M | 67.85M | 128.41M | 447.44M | 488.06M | 614.71M | 235.52M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -437.14M | -471.58M | -486.15M | -507.96M | -545.05M | -627.79M | -673.6M | -660.23M | -1.05B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -82.53M | -92.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ASPN Cash Flow Statement
Aspen Aerogels, Inc. (ASPN) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.61M | -8.65M | -1.05M | -9.92M | -18.63M | -94.4M | -42.61M | 45.55M | 32.87M |
| Operating CF Margin % | -4.13% | -8.29% | -0.76% | -9.9% | -15.32% | -52.34% | -17.85% | 10.06% | 12.13% |
| Operating CF Growth % | -696.89% | -87.89% | 87.82% | -841.56% | -87.71% | -406.76% | 54.86% | 206.89% | -27.83% |
| Net Income | -19.32M | -34.44M | -14.56M | -21.81M | -37.09M | -82.74M | -45.81M | 13.38M | -389.55M |
| Depreciation & Amortization | 10.75M | 10.79M | 10.21M | 10.2M | 9.44M | 9.22M | 18.18M | 22.53M | 45.16M |
| Stock-Based Compensation | 5.09M | 4.3M | 3.77M | 5M | 5.18M | 9.38M | 0 | 12.86M | 8.63M |
| Deferred Taxes | 0 | 10.28M | 0 | 325K | -3.82M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -112K | -121K | 947K | 980K | 1.64M | 7.9M | 16.19M | 47.75M | 320.08M |
| Working Capital Changes | -1.02M | 540K | -1.42M | -4.62M | 6.03M | -38.16M | -31.17M | -50.96M | 48.56M |
| Change in Receivables | -8.7M | -1.72M | -6.69M | 16.23M | -4.64M | -37.04M | -12.55M | -39.36M | 70.3M |
| Change in Inventory | 3.95M | 1.6M | -1.45M | -4.33M | 1.11M | -10.55M | -16.65M | -8.36M | 9.3M |
| Change in Payables | 1.27M | 1.56M | 141K | -7.15M | 7.38M | 5.32M | 4.58M | 7.34M | -19.45M |
| Cash from Investing | -6.12M | -3.59M | -2.11M | -3.42M | -13.78M | -177.97M | -175.46M | -86.26M | -37.45M |
| Capital Expenditures | -6.12M | -3.59M | -2.11M | -3.42M | -13.78M | -177.97M | -175.46M | -86.26M | -37.45M |
| CapEx % of Revenue | 5.48% | 3.44% | 1.52% | 3.41% | 11.33% | 98.67% | 73.5% | 19.05% | 13.81% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.33M | 4.88M | 3.47M | 26.2M | 92.47M | 478.37M | 75.48M | 122.02M | -58.13M |
| Debt Issued (Net) | 3.72M | 431K | -1.06M | 563K | 0 | 100M | -623K | 25.59M | -59.23M |
| Equity Issued (Net) | 0 | -551K | 0 | 24.71M | 94.42M | 391.3M | 76.52M | 93.84M | 1.87M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -391K | -551K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -391K | 5M | 4.53M | 931K | -1.95M | -12.93M | -420K | 2.59M | -765K |
| Net Change in Cash | -7.39M▲ 0% | -7.37M▲ 0.3% | 306K▲ 104.2% | 12.86M▲ 4103.6% | 60.07M▲ 367.0% | 206M▲ 242.9% | -142.59M▼ 169.2% | 81.31M▲ 157.0% | -62.71M▼ 177.1% |
| Free Cash Flow | -10.72M▲ 0% | -12.25M▼ 14.2% | -3.17M▲ 74.1% | -13.34M▼ 321.4% | -32.41M▼ 142.9% | -272.37M▼ 740.5% | -218.07M▲ 19.9% | -40.71M▲ 81.3% | -4.58M▲ 88.8% |
| FCF Margin % | -9.61% | -11.74% | -2.27% | -13.3% | -26.64% | -151.01% | -91.35% | -8.99% | -1.69% |
| FCF Growth % | 22.26% | -14.2% | 74.15% | -321.35% | -142.92% | -740.5% | 19.94% | 81.33% | 88.76% |
| FCF per Share | -0.46 | -0.52 | -0.13 | -0.51 | -1.06 | -6.92 | -3.14 | -0.51 | -0.06 |
| FCF Conversion (FCF/Net Income) | 0.24x | 0.25x | 0.07x | 0.46x | 0.50x | 1.14x | 0.93x | 3.41x | -0.08x |
| Interest Paid | 0 | 0 | 440K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ASPN Key Ratios
Aspen Aerogels, Inc. (ASPN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -10.1% | -17.85% | -40.23% | -22.54% | -34.39% | -37.8% | -28.74% | -9.79% | 2.43% | -91.64% |
| Return on Invested Capital (ROIC) | -8.99% | -14.99% | -30.81% | -15.74% | -26.2% | -48.05% | -33.71% | -9.55% | 7.59% | -9.48% |
| Gross Margin | 19.8% | 16.73% | 12.14% | 18.86% | 14.55% | 8.17% | 2.76% | 23.84% | 40.4% | 16.97% |
| Net Margin | -10.21% | -17.31% | -33% | -10.45% | -21.75% | -30.5% | -45.87% | -19.19% | 2.95% | -143.69% |
| Debt / Equity | 0.00x | 0.04x | 0.06x | 0.14x | 0.12x | 0.12x | 0.27x | 0.28x | 0.32x | 0.61x |
| Interest Coverage | -76.33x | -103.44x | -64.73x | -34.87x | -89.87x | -160.98x | -15.19x | -7.60x | 2.26x | 0.94x |
| FCF Conversion | 0.05x | 0.24x | 0.25x | 0.07x | 0.46x | 0.50x | 1.14x | 0.93x | 3.41x | -0.08x |
| Revenue Growth | -3.9% | -5.19% | -6.51% | 33.55% | -28.06% | 21.29% | 48.3% | 32.35% | 89.64% | -40.11% |
ASPN SEC Filings & Documents
Aspen Aerogels, Inc. (ASPN) SEC filings — annual & quarterly reports (10-K, 10-Q)
ASPN Frequently Asked Questions
Aspen Aerogels, Inc. (ASPN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aspen Aerogels, Inc. (ASPN) reported $271.1M in revenue for fiscal year 2025. This represents a 847% increase from $28.6M in 2009.
Aspen Aerogels, Inc. (ASPN) saw revenue decline by 40.1% over the past year.
Aspen Aerogels, Inc. (ASPN) reported a net loss of $389.6M for fiscal year 2025.
Dividend & Returns
Aspen Aerogels, Inc. (ASPN) has a return on equity (ROE) of -91.6%. Negative ROE indicates the company is unprofitable.
Aspen Aerogels, Inc. (ASPN) had negative free cash flow of $4.6M in fiscal year 2025, likely due to heavy capital investments.
Explore More ASPN
Aspen Aerogels, Inc. (ASPN) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates